Position in LLY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,207,826
+$438,899 QoQ
Shares Held
1,007
+20.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2,959
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carrera Capital Advisors holds $6,568,870 across 3 Drug Manufacturers - General names. LLY ranks #2 (18.4% of the industry book) .
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,207,826 | 1,007 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $768,927 | 836 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $938,195 | 873 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $556,227 | 729 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $526,962 | 676 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $522,801 | 633 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $290,272 | 376 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $243,633 | 275 | Shares | Sole | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||